AU5705898A - Mammalian cell surface antigens; related reagents - Google Patents

Mammalian cell surface antigens; related reagents

Info

Publication number
AU5705898A
AU5705898A AU57058/98A AU5705898A AU5705898A AU 5705898 A AU5705898 A AU 5705898A AU 57058/98 A AU57058/98 A AU 57058/98A AU 5705898 A AU5705898 A AU 5705898A AU 5705898 A AU5705898 A AU 5705898A
Authority
AU
Australia
Prior art keywords
cell surface
mammalian cell
surface antigens
related reagents
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57058/98A
Inventor
Daniel M. Gorman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU5705898A publication Critical patent/AU5705898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU57058/98A 1996-12-17 1997-12-16 Mammalian cell surface antigens; related reagents Abandoned AU5705898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3360196P 1996-12-17 1996-12-17
US60033601 1996-12-17
PCT/US1997/023321 WO1998027114A2 (en) 1996-12-17 1997-12-16 Mammalian cell surface antigens; related reagents

Publications (1)

Publication Number Publication Date
AU5705898A true AU5705898A (en) 1998-07-15

Family

ID=21871343

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57058/98A Abandoned AU5705898A (en) 1996-12-17 1997-12-16 Mammalian cell surface antigens; related reagents

Country Status (2)

Country Link
AU (1) AU5705898A (en)
WO (1) WO1998027114A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU743490B2 (en) * 1997-06-06 2002-01-24 Regeneron Pharmaceuticals, Inc. NTN-2 member of TNF ligand family

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US6689579B1 (en) 1996-10-25 2004-02-10 Human Genome Sciences, Inc. Polynucleotides encoding neutrokine-α
CA2232743A1 (en) * 1997-04-02 1998-10-02 Smithkline Beecham Corporation A tnf homologue, tl5
AU7608898A (en) * 1997-06-06 1998-12-21 Regeneron Pharmaceuticals, Inc. Ntn-2 member of tnf ligand family
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
PL339740A1 (en) * 1997-09-12 2001-01-02 Biogen Kay - a novel immune system protein
WO1999026463A2 (en) * 1997-11-26 1999-06-03 Eli Lilly And Company Tnf ligand family gene
AU2093499A (en) * 1997-12-30 1999-07-19 Chiron Corporation Members of tnf and tnfr families
US6297367B1 (en) 1997-12-30 2001-10-02 Chiron Corporation Polynucleotide encoding TNFL1
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
GB9828628D0 (en) 1998-12-23 1999-02-17 Glaxo Group Ltd Novel ligand
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
US20030095967A1 (en) 1999-01-25 2003-05-22 Mackay Fabienne BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
EA006108B1 (en) * 1999-01-25 2005-08-25 Байоджен, Инк. Method of stimulation and inhibition of b-cells, production of immunoglobulins and correction of disorders associated with baff-ligand in an animal
US6475986B1 (en) * 1999-02-02 2002-11-05 Research Development Foundation Uses of THANK, a TNF homologue that activates apoptosis
CA2363112A1 (en) * 1999-02-23 2000-08-31 Craig A. Rosen Neutrokine-alpha and neutrokine-alpha splice variant
AU4201000A (en) * 1999-04-05 2000-10-23 Incyte Pharmaceuticals, Inc. Molecules of the immune system
EP1177214A4 (en) * 1999-04-09 2003-01-02 Human Genome Sciences Inc 49 human secreted proteins
US20030022233A1 (en) 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
US6475987B1 (en) 1999-05-06 2002-11-05 National Jewish Medical And Research Center Tall-1 receptor homologues
BR0013391A (en) 1999-08-17 2002-07-09 Biogen Inc Use of the baff receptor (bcma) as an immunoregulatory agent
UA74798C2 (en) 1999-10-06 2006-02-15 Байоджен Айдек Ма Інк. Method for treating cancer in mammals using polypeptide interfering with interaction between april and its receptors
CA2897626C (en) 2000-02-11 2020-03-24 Biogen Idec Ma Inc. Heterologous polypeptide of the tnf family
DE60028830T2 (en) 2000-02-16 2007-01-18 Genentech, Inc., South San Francisco ANTI-APRIL ANTIBODIES AND HYBRIDOMA CELLS
DE60128216T2 (en) 2000-05-12 2008-01-10 Amgen Inc., Thousand Oaks Polypeptides for inhibiting the April-mediated proliferation of B and T cells
KR101155294B1 (en) 2000-06-16 2013-03-07 캠브리지 안티바디 테크놀로지 리미티드 Antibodies that immunospecifically bind to BLyS
US7220840B2 (en) 2000-06-16 2007-05-22 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator protein
AU2001288260A1 (en) * 2000-08-15 2002-03-13 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20030091565A1 (en) 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
UA83458C2 (en) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf)
JP4516719B2 (en) 2001-05-11 2010-08-04 アムジエン・インコーポレーテツド Peptides binding to TALL-1 and related molecules
ATE542545T1 (en) 2001-05-24 2012-02-15 Zymogenetics Inc TACI-IMMUNOGLOBULIN FUSION PROTEINS
AR035119A1 (en) 2001-08-16 2004-04-14 Lilly Co Eli ANTI-HTNFSF13B HUMAN ANTI-BODIES
AU2004233164B2 (en) 2003-03-28 2009-10-08 Biogen Ma Inc. Truncated BAFF receptors
ES2537738T3 (en) 2003-06-05 2015-06-11 Genentech, Inc. Combination therapy for B cell disorders
US20070249530A1 (en) * 2004-01-29 2007-10-25 Genentech, Inc. Bcma Polypeptides and Uses Thereof
ZA200702335B (en) 2004-10-05 2009-05-27 Genentech Inc Method for treating vasculitis
EP1814577B1 (en) 2004-10-13 2014-04-23 The Washington University Use of baff to treat sepsis
WO2006067210A1 (en) 2004-12-23 2006-06-29 Laboratoires Serono S.A. Bcma polypeptides and uses thereof
JP2009507777A (en) 2005-08-09 2009-02-26 ザイモジェネティクス，インコーポレイティド Method for treating B cell tumors using TACI-Ig fusion molecules
AR059025A1 (en) 2005-08-09 2008-03-12 Zymogenetics Inc METHODS FOR THE TREATMENT AND PREVENTION OF PROLIFERATION OF ABNORMAL CELLS USING TACI FUSION MOLECULES
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
CA2629306A1 (en) 2005-11-23 2007-05-31 Genentech, Inc. Methods and compositions related to b cell assays
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
EA015342B1 (en) 2006-05-15 2011-06-30 Арес Трейдинг С.А. Methods for treating autoimmune diseases using a taci-ig fusion molecule
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
BR112012004777A2 (en) 2009-09-03 2019-09-24 Genentech Inc Methods to Treat Diagnose and Monitor Rheumatoid Arthritis
CN103502472B (en) 2011-02-28 2017-06-06 弗·哈夫曼-拉罗切有限公司 Biomarker and the method for predicting the response to B cell antagonists
US9458246B2 (en) 2013-03-13 2016-10-04 Amgen Inc. Proteins specific for BAFF and B7RP1
JOP20140087B1 (en) 2013-03-13 2021-08-17 Amgen Inc Proteins specific for baff and b7rp1 and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503263A (en) * 1996-10-25 2001-03-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Neutrokine α

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU743490B2 (en) * 1997-06-06 2002-01-24 Regeneron Pharmaceuticals, Inc. NTN-2 member of TNF ligand family

Also Published As

Publication number Publication date
WO1998027114A3 (en) 1998-10-22
WO1998027114A2 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
AU5705898A (en) Mammalian cell surface antigens; related reagents
AU7103198A (en) Mammalian cytokines; related reagents and methods
AU6327798A (en) Multiple assays of cell specimens
AU8121098A (en) Cell activation process and reagents therefor
AU1967295A (en) Folded-path optical analysis cell
AU6455698A (en) Improved thin film sample support
ZA964776B (en) Mammalian cell culture process.
ZA986596B (en) Mammalian cytokine related reagents
AU5605994A (en) Methods for determining the presence of functional p53 in mammalian cells
AU4752696A (en) Monoclonal antibodies for human osteogenic cell surface antigens
AU8063798A (en) Secretory immunoglobulin produced by single cells and methods for making and using same
AU2661199A (en) Mammalian receptor proteins; related reagents and methods
AU3574997A (en) Mammalian chemokine reagents
AU1919201A (en) Mammalian receptor proteins; related reagents and methods
AU5116596A (en) Cell culture method
AU3873200A (en) Mammalian cytokines; related reagents and methods
AU7962398A (en) Mammalian genes; related reagents
AU2315195A (en) Nucleic acid mutation assays
AU2118097A (en) Sample holder for cells
AU3823795A (en) Novel mammalian protein associated with uncontrolled cell division
AU6132698A (en) Mammalian chemokines; receptors; reagents; uses
AU2246597A (en) Mammalian dendritic cell chemokine reagents
AU2824197A (en) Cell wall assay
AU6017098A (en) Mammalian chemokines; receptors; reagents; uses
AU6634298A (en) Biosensor for cells